Bispectral Index (BIS) for Classification of Procalcitonin (PCT) Sepsis Grades in Critically Ill Patients With Sepsis

ConditionSepsis, Severe

Trial statusRecruiting

Trial phaseNot listed

Trial typeObservational

Biological sexAll

AgeNot listed

SponsorSuez Canal University

About this trial

To evaluate the discriminative power of BIS monitoring to classify the degree of mental state associated with the PCT graded sepsis cascade, and to assess its utility for monitoring the improvement or deterioration of sepsis.

Eligibility criteria

This trial does not accept healthy volunteers

Qualifiers

patients with sepsis

Disqualifiers

Patients who received drugs that would interfere with BIS monitoring

Trial population

Critical Care patients with all grades of Sepsis monitored with bispectral index

Trial design

Design model

Case-only

Time perspective

Prospective

Treatments tested in this trial

no intervention
Other intervention

Treatment groups

No treatment groups listed

Trial outcomes

Primary outcomes

Bispectral Index (BIS)-Electroencephalography (EEG) derived parameter correlated to the severity of Sepsis as indicated by Procalcitonin (PCT) biomarker.

Bispectral Index (BIS)-Electroencephalography (EEG) derived parameter (scale from 0=brain dead to 100= normal EEG) will be monitored and correlated to the severity of Sepsis as indicated by daily measured Procalcitonin (PCT) biomarker (\<0.5 micg/L =no sepsis up to 100 micg/L =Septic shock)

Time frame

Time point 1= On CCU admission, Time point 2= day 3 of CCU admission, Time point 3= on release from CCU.

Sponsors and contacts

Click on the lead sponsor to view all of their trials.

Suez Canal University

Lead sponsor

Source ClinicalTrials.gov

Apply now